IRIS
BALDARI, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 29.540
NA - Nord America 22.239
AS - Asia 12.529
SA - Sud America 4.112
Continente sconosciuto - Info sul continente non disponibili 735
AF - Africa 393
OC - Oceania 34
Totale 69.582
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.742
RU - Federazione Russa 13.060
IT - Italia 5.474
SG - Singapore 5.152
BR - Brasile 3.521
CN - Cina 3.493
IE - Irlanda 3.084
SE - Svezia 2.936
HK - Hong Kong 1.285
DE - Germania 1.219
VN - Vietnam 828
FR - Francia 827
FI - Finlandia 635
GB - Regno Unito 603
IN - India 562
UA - Ucraina 525
NL - Olanda 389
CA - Canada 226
PL - Polonia 226
BD - Bangladesh 193
AR - Argentina 191
TR - Turchia 139
IQ - Iraq 133
MX - Messico 133
ZA - Sudafrica 119
BE - Belgio 110
JP - Giappone 93
CO - Colombia 85
AT - Austria 82
ES - Italia 81
EC - Ecuador 79
ID - Indonesia 79
CZ - Repubblica Ceca 73
PK - Pakistan 72
UZ - Uzbekistan 64
VE - Venezuela 60
CL - Cile 58
MA - Marocco 58
TN - Tunisia 49
CI - Costa d'Avorio 44
IR - Iran 41
AE - Emirati Arabi Uniti 40
LT - Lituania 40
SA - Arabia Saudita 40
PY - Paraguay 37
AZ - Azerbaigian 36
KE - Kenya 34
PH - Filippine 34
JM - Giamaica 32
PE - Perù 31
CH - Svizzera 29
AU - Australia 27
EG - Egitto 27
UY - Uruguay 26
MY - Malesia 24
DZ - Algeria 23
CR - Costa Rica 22
IL - Israele 22
JO - Giordania 21
KG - Kirghizistan 21
PA - Panama 21
AL - Albania 19
EU - Europa 19
KZ - Kazakistan 19
NP - Nepal 19
BO - Bolivia 18
PS - Palestinian Territory 16
RO - Romania 16
LB - Libano 15
GE - Georgia 14
HN - Honduras 13
OM - Oman 13
PT - Portogallo 12
DO - Repubblica Dominicana 11
NI - Nicaragua 11
NO - Norvegia 11
BG - Bulgaria 10
BY - Bielorussia 10
GT - Guatemala 10
HU - Ungheria 9
SN - Senegal 9
AM - Armenia 8
BH - Bahrain 8
GR - Grecia 8
HR - Croazia 7
LK - Sri Lanka 7
LV - Lettonia 7
TH - Thailandia 7
XK - ???statistics.table.value.countryCode.XK??? 7
RS - Serbia 6
DK - Danimarca 5
EE - Estonia 5
KW - Kuwait 5
MN - Mongolia 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
ET - Etiopia 4
LU - Lussemburgo 4
LY - Libia 4
Totale 68.796
Salva come PNG Salva come JPEG
Città #
Moscow 3.864
Dublin 3.079
Ashburn 3.013
Singapore 2.652
Dallas 2.476
Chandler 2.474
Nyköping 1.665
Hong Kong 1.280
Beijing 1.267
San Jose 1.218
Jacksonville 1.180
Council Bluffs 662
The Dalles 612
Los Angeles 514
Princeton 506
Medford 472
Milan 462
Munich 459
Lauterbourg 427
Rome 419
Dearborn 406
Cambridge 366
Des Moines 359
New York 357
Ann Arbor 337
Messina 327
São Paulo 282
Dong Ket 236
Boardman 228
Hyderabad 215
Buffalo 209
Ho Chi Minh City 192
Warsaw 186
Naples 181
Bremen 164
Jinan 151
Tianjin 148
Lancaster 147
Santa Clara 145
Wilmington 140
Turku 136
Redondo Beach 129
Hanoi 128
Helsinki 124
Shenyang 123
Pune 121
Orem 111
Palermo 105
Brussels 104
Catania 102
Frankfurt am Main 101
Turin 101
Woodbridge 100
Guangzhou 96
San Mateo 92
Houston 91
Rio de Janeiro 88
Bologna 84
Belo Horizonte 83
Montreal 83
Bari 81
Nanjing 76
Brasília 75
Tokyo 75
Atlanta 74
Johannesburg 71
Brooklyn 70
Chennai 70
Florence 67
Seattle 67
Curitiba 65
London 64
Denver 62
Zhengzhou 62
Porto Alegre 61
Chicago 59
Genoa 59
Vienna 59
Baghdad 57
Stockholm 57
Tashkent 57
Nuremberg 54
Phoenix 54
Hebei 52
Nanchang 51
Columbus 50
Ningbo 50
Campinas 49
Amsterdam 48
Hangzhou 47
Shanghai 46
Abidjan 44
Brno 43
Haikou 41
Manchester 40
Poplar 39
Shenzhen 39
Düsseldorf 38
Mumbai 38
San Francisco 38
Totale 37.828
Salva come PNG Salva come JPEG
Nome #
LA LOCALIZZAZIONE ISTMICA DEL NODULO TIROIDEO MALIGNO RAPPRESENTA UN FATTORE ADDIZIONALE DI RISCHIO PER METASTASI IN PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE (CDT) A BASSO RISCHIO 4.701
111In-Pentetreotide in neuroendocrine tumours. Comparison between diagnostic scintigraphy and “post-therapy” whole-body scan 332
EMIAGENESIA TIROIDEA, MORBO DI BASEDOW-GRAVES E CARCINOMA DIFFERENZIATO DELLA TIROIDE: UN’ASSOCIAZIONE MOLTO RARA. 328
153Sm-EDTMP in the treatment of painful bone metastases from prostate and breast cancer. Personal experience. 296
153Sm-EDTMP in the treatment of painful bone metastases from breast cancer. 283
186Re-HEDP in the treatment of painful bone metastases from cancers other than prostate and breast 282
99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology 280
Value of 99mTc-DPD scintigraphy as early diagnostic modality in familial amyloidotic polyneuropathy. 277
Aggressive pituitary adenomas: the dark side of the moon 277
18F-FDG PET/CT in overweight patients using a TOF LYSO PET/CT scanner: comparison of different acquisition times. 263
131I RADIOIODINE THERAPY (RIT) OF HYPERTYROIDISM DUE TO GRAVES’ DISEASE (GD) OR UNI-MULTINODULAR TOXIC GOITER (NTG): OUR EXPERIENCE 258
Acute effects of propafenone on left ventricular function in myocardial infarction 255
131I Radioiodine therapy (RIT) of hyperthyroidism due to Graves' disease (GD) or uni-multinodular toxic goiter (NTG): our experience 249
111In-Pentetreotide for treatment of neuroendocrine tumours: an alternative therapeutic option in particular cases 243
PRE- AND POSTOPERATIVE CEREBRAL PERFUSION ASSESSMENTS IN CHRONIC SUBDURAL HEMATOMA 243
Abscesualized gliomas:predictive value of 99Tc-Leukoscan 236
Ruolo dell'imaging funzionale nel management delle emorragie cerebrali atipiche: proposta di un protocollo diagnostico derivato dalla sperimentazione clinica. 235
111In-Pentetreotide in neuroendocrine tumours: comparison between diagnostic scintigraphy and “post-therapy” whole-body scan 235
Ruolo della scintigrafia con HIG 99mTc (immunoglobuline policlonali marcate) nella colite ulcerosa e nel morbo di Crohn. Risultati preliminari 229
Combined diagnosis in breast carcinoma: preoperative role of mammoscintigraphy with Tc99m-sestamibi. Our Experience 226
2D Feature Strain Echocardiography in patients with transthyretin familial amyloid plyneuropathy and diffuse cardiac 99mTc-DPD accumulation 225
[68 Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177 Lu]DOTATOC PRRT: The “Theragnomics” Concept 224
111In-Pentetreotide therapy in patients with inoperable benign intracranial tumors. 223
99mTc-MIBI SPECT in distinguishing neoplastic from nonneoplastic intracerebral hematoma 217
18F-FDG PET/CT Imaging of Prostate Stromal Tumor of Uncertain Malignant Potential 216
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 209
A didactic experiment showing the Compton scattering by means of a clinical gamma camera 208
A Single Centre Experience with 223-Radium-Dichloride ((RaCl2)-Ra-223) Therapy 205
99mTc MIBI SPET in revealing underlying neoplasms in brain hemorrhages 204
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 204
99mTc-HM-PAO SPECT evaluation of regional cerebral blood flow modifications after paediatric hydrocephalus shunting 203
Abnormal 99mTc-MIBI Uptakein left lung mimicking a neoplastic lesion in a young woman with nodular goiter. A rare pitfall of 99mTc-MIBI 202
99mTc-MIBI SPECT in the differential diagnosis of brain metastases 201
2 years-survival analysis of patients with non-small cell lung cancer by means of 2deoxy-2-[18F]fluoro-D-glucose positron emission tomography: implications of maximum standardized uptake value (SUVmax) 201
18F-FDG PET/CT Imaging of Immune Checkpoint Inhibitor-Related "Retroperitoneal Panniculitis" 201
Abnormal radioiodine uptake on post-therapy whole body scan and sodium/iodine symporter expression in a dermoid cyst of the ovary: report of a case and review of the literature 200
PRRT Retreatments: Renal Function Evaluation 200
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience 199
Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy? 199
An analytical model for improving absorbed dose calculation accuracy in non spherical autonomous functioning thyroid nodule 198
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 198
11C-Choline PET/CT based helical tomotherapy as innovative treatment approach for bone metastases in prostate cancer patients 196
Association of autonously functioning ("hot") thyroid nodules with Hashimotos' thyroiditis (HT). 194
99mTc-MIBI SPECT imaging of acute and subacute non-neoplastic brain haematomas 194
Association of parathyroid carcinoma and thyroid disorders: A clinical review 194
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 193
223RA-dichloride use in patients affected by bone metastases from castration-resistant prostate cancer: single centre experience 193
ABLAZIONE RADIOMETABOLICA DEL RESIDUO TIROIDEO POST-CHIRURGICO DOPO STIMOLO CON TSH UMANO RICOMBINANTE (rhTSH) IN PAZIENTI CON OFTALMOPATIA DI GRAVES (OG) DI GRADO MODERATAMENTE SEVERO E SEVERO: STUDIO PROSPETTICO RANDOMIZZATO IN SINGOLO CIECO 190
99mTc-methoxy-isobutyl-isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 189
90Y-dotatoc and/or 111In-pentetreotide in the treatment of somatostatin receptors-expressing tumors (SSTR): personal experience 188
[(186)Re]HEDP in the palliation of painful bone metastases from cancers otherthan prostate and breast. 187
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 187
Erratum: Mid and long-term effects on pulmonary perfusion, anatomy and diaphragamatic motility in survivors of congenital diaphragmatic hernia 186
18F-FACBC in prostate cancer: A systematic review and meta-analysis 186
Accidental discovery of lung metastases from differentiated thyroid cancer by 99mTc sodium pertechnetate scan in a patient with secondary hyperparathyroidism 185
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 185
Peptide receptor radionuclide therapy with 111IN-DTPA-Octreotide in a woman with Cabergoline-resistant giant prolactinoma 184
Hyperthyroidism treatment with calculated activity of 131-Radioiodine: our experience 184
Comparison Between 99mTc-Diphosphonate Imaging and MRI With Late Gadolinium Enhancement in Evaluating Cardiac Involvement in Patients With Transthyretin Familial Amyloid Polyneuropathy 184
Abnormal radioiodine uptake in an abdominal dermoid cyst in a patient affected by differentiated thyroid cancer 184
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 183
Constrictive Pericarditis: An Update on Noninvasive Multimodal Diagnosis 182
ACCUMULO DI TECNEZIO IN METASTASI POLMONARI DA CARCINOMA DIFFERENZIATO TIROIDEO (CDT): UNA RARA EVENIENZA 182
Diagnostic possibilities and clinical indications of policlonal labeled Ig in the bowel inflammatory disease 182
Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer 182
Complete response in a pancreatic NEN with liver metastasis after PRRT in association with lanreotide autogel/depot 182
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? 182
SPECT and MRI in Complex Partial Epilepsy. 181
Brunner's adenoma, esophageal reflux and gastric ulcer. A case report 181
A methodological approach to a realistic evaluation of skin absorbed doses during manipulation of radioactive sources by means of GAMOS Monte Carlo simulations 181
An extremely rare association of TSH-secreting pituitary adenoma, metastatic neuroendocrine tumor and Cushing’s syndrome in a patient with MEN-1 gene mutation 181
Complete Response in a Pancreatic Nen with Liver Metastasis after PRRT in association with Lanreotide Autogel/depot: Design of the Prelude Study 181
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients 180
Diagnosis of hepatic hemangiomas with 99mTc-labeled red blood cell scanning: value of SPECT 179
11c-choline pet/ct based helical tomotherapy as treatment approach for bone metastases in recurrent prostate cancer patients 179
Usefulness of PET-CT scan in recurrent thyroid cancer 177
GASTROINTESTINAL SEQUELAE IN SURVIVORS OF CONGENITAL DIAPHRAGMATIC HERNIA 176
A Monte Carlo approach to small-scale dosimetry of solid tumour microvasculature for nuclear medicine therapies with (223)Ra-, (131)I-, (177)Lu- and (111)In-labelled radiopharmaceuticals 176
Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study 176
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 176
A microdosimetric model of solid tumour microvasculature for radiopharmaceuticals labeled with 223 Ra, 111 In, 131 I and 177 Lu 175
Clinico-laboratory response and haematological toxicity in patients undergoing therapy with 223RA-dichloride 175
A Monte Carlo model for the internal dosimetry of choroid plexuses in nuclear medicine procedures 175
A simplified method for kidney dosimetry in Lu-177 therapies based on single SPECT-CT and multiple external probe measurements 175
ACCUMULO DI RADIOIODIO IN MIELOMENINGOCELE SECONDARIO A SPINA BIFIDA OCCULTA: PRIMA EVIDENZA DI CONDIZIONE SIMULANTE UNA METASTASI VERTEBRALE DI CARCINOMA DIFFERENZIATO DELLA TIROIDE 174
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 174
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low risk differentiated thyroid cancer? 174
Safety, effectiveness and haematological toxicity of 223Radichloride: a single Centre experience 174
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 173
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 173
COVID-19 Surface Persistence: A Recent Data Summary and Its Importance for Medical and Dental Settings 173
Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism 173
A model to evaluate S values for beta-gamma emitting radionuclides in cubic voxels 172
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy ina real life scenario 171
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG) 170
Cardiac 99mTc-DPD uptake in subjects with Glu89Gln transthyretin gene mutation: is it the earliest sign of disease development? 170
Effectiveness, safety and haematological toxicity of 223Ra-Cl2: a single centre experience 170
A potentially misleading finding at somatostatin receptor scintigraphy: focal pulmonary areas of intense accumulation without computed tomography-detectable lung lesions 169
Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: A new quantitative method for improving diagnostic accuracy 169
Clinical usefulness of 99mTc-MIBI scintigraphy in the postsurgical evaluation of patients with differentiated thyroid cancer 168
Totale 24.694
Salva come PNG Salva come JPEG
Categoria #
all - tutte 224.129
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 224.129
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.414 0 468 49 110 154 34 199 177 39 521 483 1.180
2022/20239.151 745 986 441 737 699 918 131 503 3.610 61 226 94
2023/20243.491 196 332 205 284 247 655 144 232 104 418 209 465
2024/202512.709 322 295 400 853 708 480 519 2.388 2.794 828 1.241 1.881
2025/202631.118 1.752 2.007 2.485 2.000 2.439 6.718 3.624 3.837 3.816 1.385 489 566
2026/20272.026 509 1.517 0 0 0 0 0 0 0 0 0 0
Totale 69.582